Pafolacianine vs Pembrolizumab
Pafolacianine vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Pafolacianine and Pembrolizumab.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Pembrolizumab β 26 days.
Chemical Properties
Type: Pafolacianine β Small molecule; Pembrolizumab β Antibody.